Nutralife Financial Statements From 2010 to 2025
Nutralife Biosciences financial statements provide useful quarterly and yearly information to potential Nutralife Biosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Nutralife Biosciences financial statements helps investors assess Nutralife Biosciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Nutralife Biosciences' valuation are summarized below:Nutralife Biosciences does not presently have any fundamental ratios for analysis.
This module can also supplement various Nutralife Biosciences Technical models . Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Check Nutralife Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nutralife Biosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Nutralife financial statements analysis is a perfect complement when working with Nutralife Biosciences Valuation or Volatility modules.
Nutralife |
Nutralife Biosciences Company Return On Equity Analysis
Nutralife Biosciences' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nutralife Biosciences Return On Equity | -14.26 |
Most of Nutralife Biosciences' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nutralife Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Nutralife Biosciences has a Return On Equity of -14.2602. This is 40.51% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is notably higher than that of the company.
Nutralife Biosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nutralife Biosciences's current stock value. Our valuation model uses many indicators to compare Nutralife Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nutralife Biosciences competition to find correlations between indicators driving Nutralife Biosciences's intrinsic value. More Info.Nutralife Biosciences is regarded third in return on equity category among its peers. It is regarded second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nutralife Biosciences' earnings, one of the primary drivers of an investment's value.Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Nutralife Pink Sheet
If you are still planning to invest in Nutralife Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nutralife Biosciences' history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |